Our study not only identifies a novel molecular mechanism underlying ATP synthesis but also highlights the aberrant KLF4/miR-206/RICTOR signaling pathway as a promising molecular target for the development of novel therapeutic strategies to control the development and progression of HCC. The gene discussed is RICTOR; the disease is hepatocellular carcinoma.